Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer

Authors

  • Line H. Dohn Department of Oncology, Herlev University Hospital, Herlev, Denmark
  • Benny V. Jensen Department of Oncology, Herlev University Hospital, Herlev, Denmark
  • Finn O. Larsen Department of Oncology, Herlev University Hospital, Herlev, Denmark

DOI:

https://doi.org/10.3109/02841860903428184

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2010-01-01

How to Cite

Dohn, L. H., Jensen, B. V., & Larsen, F. O. (2010). Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer. Acta Oncologica, 49(3), 395–396. https://doi.org/10.3109/02841860903428184

Issue

Vol. 49 No. 3 (2010): Acta Oncologica

Section

Articles